RegenXBio Balance Sheet
RegenXBio's total assets for Q4 2025 were $453.03M, a decrease of -13.74% from the previous quarter. RGNX total liabilities were $350.30M for the fiscal quarter, a -3.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.